Rate My Professor Chris Levi

Professor Levi's research specializes in translating experimental stroke therapies into clinical practice for stroke prevention and treatment, with emphasis on acute stroke therapies, interventional clinical trials including thrombolysis and antithrombotic therapy, brain imaging via multimodal CT, MRI, and transcranial Doppler, stroke genetics, observational epidemiology, and health services interventions such as cluster randomised trials. Notable projects include the QASC trial on management of fever, hyperglycemia, and swallowing disturbance in acute stroke, paramedic tools like the Hunter 8, and international trials such as ENCHANTED and EXTEND. Key publications include 'Mortality Reduction for Fever, Hyperglycemia, and Swallowing Disturbance After Ischemic Stroke: The Quality in Acute Stroke Care Study' (2016), 'Perfusion CT in Acute Stroke: A Comprehensive Analysis of Infarct Core and Penumbra' (2013), and 'Progress update on the Phase II, double-blinded, randomised, placebo-controlled study to determine the safety, preliminary efficacy and pharmacokinetics of ARG-007 in acute ischemic stroke patients (SEANCON)' (2024). His work has shaped national and state stroke management policies, enhanced regional stroke patient outcomes, and earned awards including the NHMRC Practitioner Fellowship (2013), Fellowship of the Australian Academy of Health and Medical Sciences (2015), Hunter New England Health Quality Awards in Translational Research (2015), Premier's Public Sector Awards (2007 and 2012), and Hunter Medical Research Institute Award for Research Excellence (2009).